Department Of Medicine
-
Disease-fighting antibody production
New research links nutrient-responsive cellular signaling to the antibody-mediated immune response. Read MoreApr 20, 2018
-
VUMC drug repurposing initiative gaining momentum
Drug repurposing involves establishing an additional approved indication for a drug already at market. Read MoreApr 19, 2018
-
Initiative stresses importance of advance directives
While many might prefer to not think about dying, healthcare professionals throughout the United States are encouraging patients and their families to do just that during a national awareness campaign April 16-22 that promotes the importance of completing an advance directive for healthcare. Read MoreApr 12, 2018
-
Vanderbilt scientists test potential new way to treat anemia
Treatment of anemia caused by chronic kidney disease or other diseases often requires repeated — and costly — injections or infusions of an artificial form of the hormone erythropoietin (EPO), which stimulates production of red blood cells. Read MoreApr 10, 2018
-
Patient’s efforts help shine light on plasma cell disorder
Charlotte Haffner, Vanderbilt’s first patient to undergo a heart transplant followed by a stem cell transplant to treat a plasma cell disorder called primary AL amyloidosis, now she dedicates her time to raising awareness about the rare disease. Read MoreApr 5, 2018
-
Report calls for greater awareness of rare cardiac disease
A national effort seeks to raise awareness about an uncommon cause of heart attacks in otherwise healthy, young and middle-aged women. Read MoreApr 5, 2018
-
Alzheimer’s proteins in ICU survivors
The cognitive impairment that affects patients who survive a stay in the ICU does not appear to have a similar mechanism to Alzheimer’s disease, Vanderbilt researchers have discovered. Read MoreMar 27, 2018
-
Grant bolsters study of potential new therapy for C. diff infection
According to the Centers for Disease Control and Prevention, in 2011 in the United States there were almost half a million Clostridium difficile infections, and one in 11 patients 65 or older with a healthcare-associated C. diff infection died within 30 days of diagnosis. Read MoreMar 22, 2018
-
An unexpected side effect of public health education efforts in Brazil
Understanding of tuberculosis is associated with higher, not lower, stigmatization of TB patients in Brazil, according to a new report from Vanderbilt’s Latin American Public Opinion Project. Read MoreMar 20, 2018
-
Study spots undiagnosed genetic diseases in EHR
Patients diagnosed with heart failure, stroke, infertility and kidney failure could actually be suffering from rare and undiagnosed genetic diseases. Read MoreMar 15, 2018
-
Research explores barriers to kidney disease screening
New research by Vanderbilt nephrologists highlights potential barriers that may prevent black Americans from being screened for kidney disease. Read MoreMar 15, 2018
-
Cancer immunotherapy drugs linked with more serious heart effects
Vanderbilt University Medical Center investigators have identified a growing number of serious and sometimes fatal cases of heart problems among cancer patients treated with some forms of immunotherapy. Read MoreMar 12, 2018
-
Lovly earns scholarship grant for lung cancer research
Christine Lovly, MD, PhD, assistant professor of Medicine at Vanderbilt, has received a $200,000 grant to support promising new research on lung cancer. Read MoreMar 8, 2018
-
Discovery by Vanderbilt-led group could lead to improved diabetes treatment
Vanderbilt investigators and colleagues around the country have made a major discovery that could lead to better ways to treat type 1 diabetes (T1D). Read MoreMar 6, 2018
-
Saline use on decline at Vanderbilt following landmark studies
Vanderbilt University Medical Center is encouraging its medical providers to stop using saline as intravenous fluid therapy for most patients, a change provoked by two companion landmark studies released Feb. 27 that are anticipated to improve survival and decrease kidney complications. Read MoreFeb 27, 2018
-
Schlendorf named adult heart transplant medical director
Kelly Schlendorf, MD, MHS, assistant professor of Medicine, has been named medical director of Vanderbilt University Medical Center’s (VUMC) Adult Heart Transplant Program. Read MoreFeb 15, 2018
-
Protecting transplanted lungs
Acetaminophen may offer a simple treatment to prevent tissue injury following lung transplant, Vanderbilt researchers have discovered. Read MoreFeb 12, 2018
-
Study seeks to boost breast tumor immune response
Immunotherapy, which harnesses the power of the immune system, is one of the most promising forms of cancer therapy and has been shown to work well against some types of cancer. Read MoreFeb 8, 2018
-
AIDS-defining events increase mortality risk: study
When they occur among people living with HIV, certain cancers and opportunistic infections are considered by health authorities as AIDS-defining events, or ADEs. Read MoreFeb 8, 2018
-
Study tracks therapy to slow idiopathic pulmonary fibrosis
Investigators in the Division of Allergy, Pulmonary and Critical Care have launched a pilot study to see if patients with idiopathic pulmonary fibrosis (IPF) can tolerate the addition of a commonly used antiviral drug to standard IPF treatments. The research team believes the drug may ultimately help slow progression of the chronic and progressive disease or reverse its course. Read MoreFeb 1, 2018